Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Makhni Svetlana Ni — Prime Medicine, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Makhni Svetlana Ni

Makhni Svetlana Ni

Chief Financial Officer at Prime Medicine, Inc. · on record since Apr 17, 2026

Insider trading activity of Makhni Svetlana Ni

Transactions on record: 1; since Apr 17, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 17, 2026

Figures computed from official regulatory filings — methodology.

Companies where Makhni Svetlana Ni has traded

Prime Medicine, Inc.1 tx · Apr 17, 2026

Track record of Makhni Svetlana Ni

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Makhni Svetlana Ni

Co-insiders of Makhni Svetlana Ni

Alenson CarmanPrime Medicine, Inc.
Alphabet Inc.Prime Medicine, Inc.
ARCH Venture Fund XII, L.P.Prime Medicine, Inc.
ARCH Venture Fund X, L.P.Prime Medicine, Inc.
ARCH Venture Fund X Overage, L.P.Prime Medicine, Inc.
ARCH Venture Partners XII, LLCPrime Medicine, Inc.
ARCH Venture Partners XII, L.P.Prime Medicine, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

ARCH Venture Partners X, LLCPrime Medicine, Inc.

ARCH Venture Partners X, L.P.Prime Medicine, Inc.

ARCH Venture Partners X Overage, L.P.Prime Medicine, Inc.

Brudnick RichardPrime Medicine, Inc.

Burow KristinaPrime Medicine, Inc.

Cahill ThomasPrime Medicine, Inc.

Chung WendyPrime Medicine, Inc.

CRANDELL KEITHPrime Medicine, Inc.

Duffield JeremyPrime Medicine, Inc.

FMR LLCPrime Medicine, Inc.

Foster-Cheek Kaye IPrime Medicine, Inc.

GILLIS STEVENPrime Medicine, Inc.

Goldwasser MeredithPrime Medicine, Inc.

Gottesdiener Keith MichaelPrime Medicine, Inc.

GV 2019 GP, L.L.C.Prime Medicine, Inc.

GV 2019 GP, L.P.Prime Medicine, Inc.

GV 2019, L.P.Prime Medicine, Inc.

GV 2021 GP, L.L.C.Prime Medicine, Inc.

GV 2021 GP, L.P.Prime Medicine, Inc.

GV 2021, L.P.Prime Medicine, Inc.

GV 2023 GP, L.L.C.Prime Medicine, Inc.

GV 2023 GP, L.P.Prime Medicine, Inc.

GV 2023, L.P.Prime Medicine, Inc.

Kelly Michael AaronPrime Medicine, Inc.

LEE ANN L.Prime Medicine, Inc.

Liu David R.Prime Medicine, Inc.

Marrazzo Jeffrey DPrime Medicine, Inc.

NELSEN ROBERTPrime Medicine, Inc.

Reine AllanPrime Medicine, Inc.

Schenkein David PPrime Medicine, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Prime Medicine, Inc.	Apr 17, 2026	AwardD	800,000	0.00 USD	$0	SEC